Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed GlioblastomaRoger Stupp, Michael Weller, Monika E. Hegi et al.|Journal of Clinical Oncology|2010Cited by 445
Safety of cladribine tablets in the treatment of patients with multiple sclerosis: An integrated analysisStuart D. Cook, Elke Sylvester, Christine Hicking et al.|Multiple Sclerosis and Related Disorders|2018Cited by 122
Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)Jan B. Vermorken, Paul M. Clément, Frédéric Peyrade et al.|Annals of Oncology|2014Cited by 95